New York A01248 prohibits the sale of xylazine to individuals under 21 without proof of veterinary, institutional, or scientific use.

New York A01248 amends the general business law to prohibit the sale, offer for sale, or delivery of xylazine to individuals under the age of 21 without proof of its intended use for institutional, veterinary, or scientific purposes. This includes requiring a copy of the individual's active license to practice veterinary medicine or an affidavit stating they are not prohibited from purchasing xylazine. Businesses found in violation face civil penalties, with funds collected deposited in the New York state drug treatment and public education fund.

New York A01248 prohibits the sale of xylazine to individuals under 21 without proof of veterinary, institutional, or scientific use.

New York A01248 amends the general business law to prohibit the sale, offer for sale, or delivery of xylazine to individuals under the age of 21 without proof of its intended use for institutional, veterinary, or scientific purposes. This includes requiring a copy of the individual's active license to practice veterinary medicine or an affidavit stating they are not prohibited from purchasing xylazine. Businesses found in violation face civil penalties, with funds collected deposited in the New York state drug treatment and public education fund.